Health ❯ Healthcare ❯ Medical Research

Drug Development

AI in Medicine Eli Lilly Motor Neuron Disease Organoids AstraZeneca Eculizumab Trials Artificial Intelligence in Medicine Anti-inflammatory Treatments Antiviral Therapies Clinical Trials Obesity Treatments Immunotherapy Semaglutide Research Alzheimer's Treatments Pharmaceutical Testing Alzheimer's Disease Clinical Studies Combination Therapy Insmed Pharmaceuticals Machine Learning in Medicine New Formulations Lecanemab Bristol Myers Squibb Targeted Therapy Rare Diseases Weekly Insulin AbbVie AI in Drug Discovery RNA Aptamers Monoclonal Antibodies Nonfactor Therapies Antibiotic Resistance

AI Pipeline Finds Two Novel Antibiotic Leads Against Drug‑Resistant Gonorrhea

A graph neural network that screened millions of virtual compounds produced two preclinical hits, offering a faster route to new drug candidates while those leads still require optimization and human testing.

FDA Expands Hympavzi Approval to Patients Aged 6 and Older With Hemophilia

DeepMind and Edison Publish AI ‘Scientist’ Systems as Edison Seals Incyte Deal

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

FDA Approves Koselugo for Adults With NF1-Related Plexiform Neurofibromas

TIM‑3 Triplet Therapy Shows Promise in Immunotherapy‑Resistant Melanoma Models

FDA Approves Brensocatib as First Treatment for Non-Cystic Fibrosis Bronchiectasis

Six-Month Eculizumab Withdrawal Safe for Most aHUS Patients, Study Finds